Provided by Tiger Trade Technology Pte. Ltd.

Twist Bioscience Corp

139.00
-2.3800-1.68%
Post-market: 140.111.11+0.80%19:46 EDT
Volume:1.89M
Turnover:260.78M
Market Cap:8.72B
PE:-62.35
High:140.60
Open:139.99
Low:135.00
Close:141.38
52wk High:155.44
52wk Low:23.30
Shares:62.71M
Float Shares:61.76M
Volume Ratio:1.22
T/O Rate:3.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2293
EPS(LYR):-1.2987
ROE:-29.59%
ROA:-13.09%
PB:19.55
PE(LYR):-107.03

Loading ...

These Analysts Boost Their Forecasts On Twist Bioscience After Q2 Results

Benzinga Earnings
·
May 06

Stock Track | Twist Bioscience Soars 5.87% Intraday on Analyst Upgrades and New Hire Equity Grants

Stock Track
·
May 05

BRIEF-Twist Bioscience Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
May 05

Twist Bioscience Is Maintained at Outperform by Baird

Dow Jones
·
May 05

Twist Bioscience grants 115,279 inducement equity awards to newly hired employees

Reuters
·
May 05

Twist Bioscience (TWST) Gets a Buy from Guggenheim

TIPRANKS
·
May 05

Leerink Upgrades Twist Bioscience to Outperform From Market Perform, Adjusts Price Target to $70 From $55

MT Newswires Live
·
May 05

Twist Bioscience : Barclays Raises Target Price to $65 From $55

THOMSON REUTERS
·
May 05

Twist Bioscience upgraded to Outperform from Market Perform at Leerink

TIPRANKS
·
May 05

Twist Bioscience Corp : Leerink Partners Raises to Outperform From Market Perform; Raises Target Price to $70 From $55

THOMSON REUTERS
·
May 05

Twist Bioscience Corp : TD Cowen Raises Target Price to $68 From $58

THOMSON REUTERS
·
May 05

Twist Bioscience price target raised to $65 from $55 at Barclays

TIPRANKS
·
May 05

Stock Track | Twist Bioscience Plummets 5.97% Intraday After Reporting Wider-Than-Expected Quarterly Loss

Stock Track
·
May 04

Twist Bioscience Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 04

Twist Bioscience Outlook FY Revenue USD 442-447 Million

THOMSON REUTERS
·
May 04

Twist Bioscience FY26 Q2 net loss widens to $44 million; revenue rises 19% to $110.7 million

Reuters
·
May 04

GUIDANCE: (TWST) Twist Bioscience Expects Fiscal Q3 Revenue Range $114M to $115M, vs. FactSet Est of $111.3M

MT Newswires Live
·
May 04

Earnings Flash (TWST) Twist Bioscience Posts Fiscal Q2 Loss $0.71 a Share, vs. FactSet Est of $0.50 Loss

MT Newswires Live
·
May 04

Twist Bioscience posts fiscal 2026 Q2 earnings report, investor presentation online

Reuters
·
May 04

Twist Bioscience Announces Fiscal 2026 Second Quarter Financial Results

THOMSON REUTERS
·
May 04